Whitehawk Therapeutics Inc
WHWK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $85,415 | $55,182 | $288,816 | $214,240 |
| - Cash | $28,670 | $62,888 | $39,019 | $148,989 |
| + Debt | $833 | $1,267 | $1,661 | $605 |
| Enterprise Value | $57,578 | -$6,439 | $251,458 | $65,856 |
| Revenue | $25,983 | $24,354 | $15,216 | $1,120 |
| % Growth | 6.7% | 60.1% | 1,258.6% | – |
| Gross Profit | -$28,071 | -$27,384 | -$18,781 | -$18,550 |
| % Margin | -108% | -112.4% | -123.4% | -1,656.3% |
| EBITDA | -$64,627 | -$71,764 | -$58,798 | -$36,956 |
| % Margin | -248.7% | -294.7% | -386.4% | -3,299.6% |
| Net Income | -$63,691 | -$65,765 | -$60,513 | -$110,090 |
| % Margin | -245.1% | -270% | -397.7% | -9,829.5% |
| EPS Diluted | -2.36 | -2.44 | -2.69 | -12.41 |
| % Growth | 3.3% | 9.3% | 78.3% | – |
| Operating Cash Flow | -$59,550 | -$59,663 | -$49,640 | -$22,423 |
| Capital Expenditures | -$1,654 | -$3,972 | -$444 | -$46 |
| Free Cash Flow | -$61,204 | -$63,635 | -$50,084 | -$22,469 |